Replies to post #371522 on Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

This has been my core concern related to EUA and The Accountant believing he can 'go it alone'.

IF results are made public, and IF they're positive, and IF there's any BP interest (or otherwise), we would likely need a partnership/license/acquisition for things to go anywhere. Could be a massive grant, direct contract/DPA authorization, etc., but I don't see this happening from the virtual office in Wakefield alone.

Where's the data, Leo?

The Supply Information section, which focused solely on Baricitinib, showed extreme care on the FDA's part to assure the availability of the drug, which is approved for other uses. The numbers are thoroughly redacted but the FDA made a concerted effort to secure the data needed (inventory, production capacity, dosages) to assure that supply of Baricitinib was or could be adequate. Again as you might expect (and I fail to grasp) the issue of adequate remdesivir wasn't mentioned. It will be interesting to see what IPIX has for supply support should an application be submitted.